| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hematoma, Subdural | D006408 | 3 associated lipids |
| Hemophilia A | D006467 | 10 associated lipids |
| Hepatitis C | D006526 | 7 associated lipids |
| Carcinoma, Hepatocellular | D006528 | 140 associated lipids |
| Hip Dislocation | D006617 | 1 associated lipids |
| Hip Fractures | D006620 | 2 associated lipids |
| Hirsutism | D006628 | 3 associated lipids |
| Histiocytosis, Langerhans-Cell | D006646 | 1 associated lipids |
| HIV Seropositivity | D006679 | 15 associated lipids |
| Hyperalgesia | D006930 | 42 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Ashcroft AJ et al. | Colonic dendritic cells, intestinal inflammation, and T cell-mediated bone destruction are modulated by recombinant osteoprotegerin. | 2003 | Immunity | pmid:14670302 |
| Chong B et al. | Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype. | 2003 | J. Bone Miner. Res. | pmid:14672344 |
| Nielsen KL et al. | Biglycan deficiency interferes with ovariectomy-induced bone loss. | 2003 | J. Bone Miner. Res. | pmid:14672350 |
| Nitta K et al. | The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. | 2003 | Am. J. Kidney Dis. | pmid:12900812 |
| Fizazi K et al. | Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. | 2003 | Clin. Cancer Res. | pmid:12855635 |
| Okuma K et al. | Development of a novel surrogate virus for human T-cell leukemia virus type 1: inhibition of infection by osteoprotegerin. | 2003 | J. Virol. | pmid:12857926 |
| Sakurai A et al. | Streptococcus pyogenes infection induces septic arthritis with increased production of the receptor activator of the NF-kappaB ligand. | 2003 | Infect. Immun. | pmid:14500523 |
| Kim HH et al. | RANKL regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. | 2003 | FASEB J. | pmid:14500543 |
| Nakamura M et al. | Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. | 2003 | Endocrinology | pmid:14500574 |
| Wagner EF and Matsuo K | Signalling in osteoclasts and the role of Fos/AP1 proteins. | 2003 | Ann. Rheum. Dis. | pmid:14532157 |
| Ueland T et al. | Growth hormone substitution increases gene expression of members of the IGF family in cortical bone from women with adult onset growth hormone deficiency--relationship with bone turn-over. | 2003 | Bone | pmid:14555269 |
| Koshihara Y et al. | Vitamin K stimulates osteoblastogenesis and inhibits osteoclastogenesis in human bone marrow cell culture. | 2003 | J. Endocrinol. | pmid:12630919 |
| Alvarez L et al. | Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates. | 2003 | Arthritis Rheum. | pmid:12632438 |
| Terpos E et al. | Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. | 2003 | Blood | pmid:12689925 |
| Zheng B et al. | MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. | 2003 | Blood | pmid:12689928 |
| Sordillo EM and Pearse RN | RANK-Fc: a therapeutic antagonist for RANK-L in myeloma. | 2003 | Cancer | pmid:12548579 |
| Oyajobi BO and Mundy GR | Receptor activator of NF-kappaB ligand, macrophage inflammatory protein-1alpha, and the proteasome: novel therapeutic targets in myeloma. | 2003 | Cancer | pmid:12548580 |
| Croucher PI et al. | Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease. | 2003 | Cancer | pmid:12548581 |
| Liu JZ et al. | [Construction and biological activity study of human osteoprotegerin expressing adenoviral system]. | 2003 | Sheng Wu Gong Cheng Xue Bao | pmid:15969033 |
| Walsh MC and Choi Y | Biology of the TRANCE axis. | 2003 Jun-Aug | Cytokine Growth Factor Rev. | pmid:12787563 |
| Smith BB et al. | A toxicity profile of osteoprotegerin in the cynomolgus monkey. | 2003 Sep-Oct | Int. J. Toxicol. | pmid:14555415 |
| Theoleyre S et al. | The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. | 2004 | Cytokine Growth Factor Rev. | pmid:15561602 |
| Mori T et al. | RNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor family. | 2004 | Nucleic Acids Res. | pmid:15562003 |
| Ling JQ and Li JP | [Insulin-like growth factor-II and basic fibroblast growth factor affect periodontal ligament cells expressing osteoprotegerin in vitro]. | 2004 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:15562643 |
| Zhang D et al. | [Expression of OPG and RANKL at protein level in human periodontal ligament cells and the effect of 1alpha,25(OH)(2) vitamin D(3) on the secretion of OPG protein in vitro]. | 2004 | Beijing Da Xue Xue Bao | pmid:15605102 |
| Kumamoto H and Ooya K | Expression of parathyroid hormone-related protein (PTHrP), osteoclast differentiation factor (ODF)/receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoclastogenesis inhibitory factor (OCIF)/osteoprotegerin (OPG) in ameloblastomas. | 2004 | J. Oral Pathol. Med. | pmid:14675140 |
| Suda K et al. | Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation. | 2004 | J. Immunol. | pmid:14764723 |
| Brubaker KD et al. | Bone morphogenetic protein signaling in prostate cancer cell lines. | 2004 | J. Cell. Biochem. | pmid:14689587 |
| Zhang D et al. | The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1alpha,25-dihydroxyvitamin D3. | 2004 | Arch. Oral Biol. | pmid:14693199 |
| Guillonneau C et al. | The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection. | 2004 | J. Immunol. | pmid:14734743 |
| Miyaura C | [LPS]. | 2004 | Nippon Rinsho | pmid:15035108 |
| Tanaka Y | [Adhesion molecules in the context with bone remodeling and osteoporosis]. | 2004 | Nippon Rinsho | pmid:15035110 |
| Tomoyasu A and Higashio K | [Osteoclastogenesis inhibitory factor/osteoprotegerin(OCIF/OPG)]. | 2004 | Nippon Rinsho | pmid:15035190 |
| Sohen S | [Glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis and collagen diseases]. | 2004 | Nippon Rinsho | pmid:15035207 |
| Tanaka Y | [Secondary osteoporosis due to systemic autoimmune diseases and rheumatic diseases]. | 2004 | Nippon Rinsho | pmid:15035208 |
| Fukunaga J and Sugahara T | [Osteoporosis induced by immunosuppressant]. | 2004 | Nippon Rinsho | pmid:15035219 |
| Juji T and Tanaka S | [Novel therapeutic approach to bone metabolic disorders using RANKL vaccination]. | 2004 | Nippon Rinsho | pmid:15035230 |
| Huang JC et al. | PTH differentially regulates expression of RANKL and OPG. | 2004 | J. Bone Miner. Res. | pmid:14969393 |
| He J et al. | Emdogain promotes osteoblast proliferation and differentiation and stimulates osteoprotegerin expression. | 2004 | Oral Surg Oral Med Oral Pathol Oral Radiol Endod | pmid:14970783 |
| Ohazama A et al. | Opg, Rank, and Rankl in tooth development: co-ordination of odontogenesis and osteogenesis. | 2004 | J. Dent. Res. | pmid:14981127 |
| Naumann U et al. | Expression and functional activity of osteoprotegerin in human malignant gliomas. | 2004 | Acta Neuropathol. | pmid:14504888 |
| Saidenberg-Kermanac'h N et al. | Interleukin-4 cellular gene therapy and osteoprotegerin decrease inflammation-associated bone resorption in collagen-induced arthritis. | 2004 | J. Clin. Immunol. | pmid:15163893 |
| Melhus H | Soluble RANKL and risk of nontraumatic fracture. | 2004 | JAMA | pmid:15187049 |
| Pennisi P et al. | Low bone density and abnormal bone turnover in patients with atherosclerosis of peripheral vessels. | 2004 | Osteoporos Int | pmid:14661073 |
| Brändström H et al. | Single nucleotide polymorphisms in the human gene for osteoprotegerin are not related to bone mineral density or fracture in elderly women. | 2004 | Calcif. Tissue Int. | pmid:14508625 |
| Wang JC et al. | Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG). | 2004 | Exp. Hematol. | pmid:15504545 |
| Chen Q et al. | Testosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells. | 2004 | Horm. Metab. Res. | pmid:15523591 |
| Saidenberg-Kermanac'h N et al. | TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. | 2004 | Bone | pmid:15542046 |
| Boabaid F et al. | The role of parathyroid hormone-related protein in the regulation of osteoclastogenesis by cementoblasts. | 2004 | J. Periodontol. | pmid:15515341 |
| Franck H et al. | Evaluation of bone mineral density, hormones, biochemical markers of bone metabolism, and osteoprotegerin serum levels in patients with ankylosing spondylitis. | 2004 | J. Rheumatol. | pmid:15517638 |
| Ueland T | Bone metabolism in relation to alterations in systemic growth hormone. | 2004 | Growth Horm. IGF Res. | pmid:15519248 |
| Kitaura H et al. | Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo. | 2004 | J. Immunol. | pmid:15470024 |
| Notoya M et al. | Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells. | 2004 | Biochem. Biophys. Res. Commun. | pmid:15474477 |
| Yip KH et al. | Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity. | 2004 | J. Bone Miner. Res. | pmid:15476591 |
| Price PA et al. | Serum levels of the fetuin-mineral complex correlate with artery calcification in the rat. | 2004 | J. Biol. Chem. | pmid:14578360 |
| Tian QX and Huang GY | [Effects of 1,25-dihydroxyvitamin D3 on the expressions of osteoprotegerin and receptor activator of NF-kappaB ligand in mouse osteoblasts]. | 2004 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | pmid:15379268 |
| Nitta K et al. | Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. | 2004 | Am. J. Kidney Dis. | pmid:15384019 |
| Wang L et al. | Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34). | 2004 | J. Bone Miner. Res. | pmid:15355561 |
| Nyambo R et al. | Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis. | 2004 | J. Bone Miner. Res. | pmid:15355567 |
| Sato K | [Osteoclast-activating factors (OAF)]. | 2004 | Nippon Rinsho | pmid:15658306 |
| Politou M et al. | Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS). | 2004 | Br. J. Haematol. | pmid:15327520 |
| Erdogan B et al. | Intima-media thickness of the carotid arteries is related to serum osteoprotegerin levels in healthy postmenopausal women. | 2004 | Neurol. Res. | pmid:15327755 |
| Hofbauer LC and Schoppet M | Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. | 2004 | JAMA | pmid:15280347 |
| Kanatani M et al. | Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction. | 2004 | J. Cell. Physiol. | pmid:15281085 |
| Matsuo K and Ray N | Osteoclasts, mononuclear phagocytes, and c-Fos: new insight into osteoimmunology. | 2004 | Keio J Med | pmid:15247511 |
| Mosheimer BA et al. | Expression and function of RANK in human monocyte chemotaxis. | 2004 | Arthritis Rheum. | pmid:15248232 |
| Xu D et al. | Development of a chimaeric receptor approach to study signalling by tumour necrosis factor receptor family members. | 2004 | Biochem. J. | pmid:15250821 |
| De Leenheer E et al. | Evidence of a role for RANKL in the development of myeloma bone disease. | 2004 | Curr Opin Pharmacol | pmid:15251126 |
| Jung K et al. | Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications. | 2004 | Int. J. Cancer | pmid:15252851 |
| Giuliani N et al. | Update on the pathogenesis of osteolysis in multiple myeloma patients. | 2004 | Acta Biomed | pmid:15796087 |
| Livshits G et al. | Genetic influences on the circulating cytokines involved in osteoclastogenesis. | 2004 | J. Med. Genet. | pmid:15173242 |
| De Wilde A et al. | A low dose of daidzein acts as an ERbeta-selective agonist in trabecular osteoblasts of young female piglets. | 2004 | J. Cell. Physiol. | pmid:15174095 |
| Taranta A et al. | Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease. | 2004 | J. Bone Miner. Res. | pmid:15176994 |
| Coetzee M and Kruger MC | Osteoprotegerin-receptor activator of nuclear factor-kappaB ligand ratio: a new approach to osteoporosis treatment? | 2004 | South. Med. J. | pmid:15180028 |
| Abedin M et al. | Vascular calcification: mechanisms and clinical ramifications. | 2004 | Arterioscler. Thromb. Vasc. Biol. | pmid:15155384 |
| Vidal K et al. | Osteoprotegerin in human milk: a potential role in the regulation of bone metabolism and immune development. | 2004 | Pediatr. Res. | pmid:15155868 |
| Xiao HL et al. | Expression and identification of mutated osteoprotegerin in culture cells and larvae of silkworm. | 2004 | Acta Biochim. Biophys. Sin. (Shanghai) | pmid:15156274 |
| Kim HH et al. | Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge. | 2004 | Biochem. Pharmacol. | pmid:15081864 |
| Naumnik W et al. | Serum levels of osteoprotegerin (OPG) and pro gastrin releasing peptide (ProGRP) during chemotherapy of lung cancer. | 2004 | Rocz. Akad. Med. Bialymst. | pmid:15638385 |
| Franchimont N et al. | Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients. | 2004 | Clin. Exp. Immunol. | pmid:15544627 |
| O' Gradaigh D et al. | Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts. | 2004 | Ann. Rheum. Dis. | pmid:15020327 |
| Ichinose Y et al. | Osteoclastogenesis inhibitory factor/osteoprotegerin reduced bone loss induced by mechanical unloading. | 2004 | Calcif. Tissue Int. | pmid:15549649 |
| Collantes Estévez E and González DomÃnguez J | [Bone Paget's disease in the young adult]. | 2004 | Rev Clin Esp | pmid:15456600 |
| Collin-Osdoby P | Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. | 2004 | Circ. Res. | pmid:15564564 |
| Sato N et al. | MyD88 but not TRIF is essential for osteoclastogenesis induced by lipopolysaccharide, diacyl lipopeptide, and IL-1alpha. | 2004 | J. Exp. Med. | pmid:15353553 |
| Neville-Webbe HL et al. | Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis. | 2004 | Breast Cancer Res. Treat. | pmid:15567943 |
| Mizutani Y et al. | Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma. | 2004 | Cancer | pmid:15386310 |
| Fang TY et al. | [Serum osteoprotegrin and serum bone gamma-carboxyglutamine acid-containing protein are correlated with bone mineral density in normal women]. | 2004 | Zhonghua Yi Xue Za Zhi | pmid:15569454 |
| Hao C et al. | Modulation of TRAIL signaling complex. | 2004 | Vitam. Horm. | pmid:15110173 |
| Kiechl S et al. | Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease. | 2004 | Circulation | pmid:15117849 |
| Pritzker LB et al. | The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival. | 2004 | Mol. Biol. Cell | pmid:15064358 |
| Salmon P | Loss of chaotic trabecular structure in OPG-deficient juvenile Paget's disease patients indicates a chaogenic role for OPG in nonlinear pattern formation of trabecular bone. | 2004 | J. Bone Miner. Res. | pmid:15068491 |
| Morabito N et al. | Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle. | 2004 | J. Bone Miner. Res. | pmid:15068494 |
| Durán A et al. | The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis. | 2004 | Dev. Cell | pmid:14960283 |
| Wang FS et al. | Nitric oxide donor increases osteoprotegerin production and osteoclastogenesis inhibitory activity in bone marrow stromal cells from ovariectomized rats. | 2004 | Endocrinology | pmid:14962990 |
| Harashima SI et al. | Osteoprotegerin and receptor activator of nuclear factor kappaB ligand expression in fibroblast-like synoviocytes from rheumatoid arthritis and osteoarthritis patients. | 2004 | Rheumatology (Oxford) | pmid:14963213 |
| Hofbauer LC et al. | Effects of oral contraceptives on circulating osteoprotegerin and soluble RANK ligand serum levels in healthy young women. | 2004 | Clin. Endocrinol. (Oxf) | pmid:14725683 |
| Yoneda T et al. | Estrogen deficiency accelerates murine autoimmune arthritis associated with receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenesis. | 2004 | Endocrinology | pmid:14726437 |
| Kanzaki H et al. | Local OPG gene transfer to periodontal tissue inhibits orthodontic tooth movement. | 2004 | J. Dent. Res. | pmid:15557398 |
| Zhang X et al. | Synovial fibroblasts infected with Salmonella enterica serovar Typhimurium mediate osteoclast differentiation and activation. | 2004 | Infect. Immun. | pmid:15557643 |